The complex world of polysaccharides edited by Desiree Nedra Karunaratne

 

The Complex World of Polysaccharides 

612 

The results described in the current work demonstrated the wide range of possibilities in the 

studies of interaction between chitosan, used in diets as anti-obesity supplement, and 

molecules that are present in the human body, as well as with other drugs. Moreover, our 

work demonstrates the need for more studies on the subject as a means of providing 

information on the use of chitosan in diets as anti-obesity supplement. 

Author details 

Máira Regina Rodrigues

*

 

Universidade Federal Fluminense, Polo Universitário de Rio das Ostras, Rio das Ostras, RJ, Brazil 

Alexandre de Souza e Silva and Fábio Vieira Lacerda 

Centro Universitário de Itajubá, Instituto de Ciências Biológicas, BairroVarginha, Itajubá,  

MG, Brazil 

Acknowledgement 

The authors thank CNPq and FAPESP for the financial support. 

5. References 

Alda, M.J.L.; Parceiro, P.; Goicoechea, A.G. (1996). Rapid zero-order and second-derivative 

UV spectrophotometric determination of cyanocobalamin in pharmaceutical 

formulations containing dextran and preservatives. Journal  of  Pharmaceutical  and 

Biomedical Analysis, 14:363-365. 

Aslander-van Vliet, E.; Smart, C.; Waldron, S. (2007). Nutritional management in childhood 

and adolescent diabetes. Pediatric Diabetes, 8:323-339. 

Association of Official Analytical Chemists. (2005). Official Methods of Analysis of the 

Association Analytical Chemists. 18th ed. Gaithersburg, MD: AOAC. 

Barbosa, L.S.; Pazdziora, A.Z.; Kojima, A.S.G.; Martins, M.S.F.; Ferreira, C.L.P.; Macêdo, 

G.S.; Latorraca, M.Q.; Gomes-da-Silva, M.H.G. (2007). Effects of chitosan over some 

nutritional and biochemical parameters in rats. Journal  of  Brazilian Society  of  Food  and 

Nutrition, 32:1-13. 

Böer, U.; Noll,

 

C.; Cierny, I.; Krause,

 

D.; Hiemke, C.; Knepel, W. (2010). A common 

mechanism of action of the selective serotonin reuptake inhibitors citalopram and 

fluoxetine: Reversal of chronic psychosocial stress-induced increase in CRE/CREB-

directed gene transcription in transgenic reporter gene mice. European  Journal of 

Pharmacology, 633:33-38. 

British Pharmacopoeia. (1998). Her Majesty’s Stationery Office, London, p.413. 

Cummings, J.H.; Roberfroid, M.B.; Andersson, H.; Barth, C.; Ferro-Luzzi, A.; Ghoos, Y.; 

Gibney, M.; Hermansen, K.; James, W.P.T.; Korver, O.; Lairon, D.; Pascal, G.; Voragen, 

                                                                 

*

 Corresponding Author 

---

The Chitosan as Dietary Fiber: An in vitro Comparative  

Study of Interactions with Drug and Nutritional Substances  613 

A.G.S. (2010). A new look at dietary carbohydrate: chemistry, physiology and health. 

European Journal of Clinical Nutrition, 64:334-339. 

Dacome, L. (2005). Useless and pernicious matter: corpulence in eighteenth-century britain. 

In:  Cultures of the abdomen: diet, digestion and fat in the modern world. Eds: A. Carden-

Coyne and C. Forth. Palgrave, New York. 

Darwish, I.A. (2005). Development and validation of spectrophotometric methods for 

determination of fluoxetine, sertraline, and paroxetine in pharmaceutical dosage forms. 

Journal of AOAC International, 88:38-45. 

Deuchi, K.; Kanauchi, O.; Imasato, Y.; Kobayashi, E. (1994). Decreasing effect of chitosan on 

the apparent fat digestibility by rats fed on a high-fat diet. Bioscience  Biotechnology & 

Biochemistry, 58:1613-1616. 

Fregonezi-Nery, M.M.; Baracat, M.M.; Casagrande, R.; Machado, H.T.; Miglioranza, B.; 

Gianotto, E.A.S. (2008). Validação de métodos para determinação de fluoxetina em 

cápsulas. Química Nova, 31:1665-1669. 

Gades, M.D.; Stern, J.S. (2005). Chitosan supplementation and fat absorption in men and 

women. Journal of the American Dietetic Association, 105:72-77. 

Gomes, A.J.; Faustino, A.S.; Machado, A.E.H.; Zaniquelli, M.E.; Rigoletto, T.P.; Lunardi, C.N. 

(2006). Characterization of PLGA microparticle as a drug carrier for the compound 3-

ethoxycarbonyl-2H-benzofuro[3,2-d]-1-benzopyran-2-one. Ultra structural study of 

cellular up take and intracellular distribution. Drug Delivery, 13:447–454. 

Gomes, A.J.; Assunção, R.M.N.; Rodrigues Filho, G.; Espreafico, E.M.; Machado, A.E.H. 

(2007). Preparation and characterization of poly(D,L-lactic-co-glycolicacid) 

nanoparticles containing 3-(benzoxazol-2-yl)-7-(N,N-diethylamino)cromen-2-one. 

Journal of Applied Polymer Science, 105:964–972. 

Hennen, W.J. (2005). Chitosan. Woodland Publishing Inc., Pleasant Grove, Utah. 

Hirano, S.; Akiyama, Y. (1995). Absence of a hypocholesterolaemic action of chitosan in 

high-serum-cholesterol rabbits. Journal of the Science of Food and Agriculture, 69:91-94. 

Ho, S.C.; Tai, E.S.; Eng, P.H.; Tan, C.E.; Fok, A.C. (2001). In the absence of dietary 

surveillance, chitosan does not reduce plasma lipids or obesity in 

hypercholesterolaemic obese Asian subjects. The Singapore Medical Journal, 42:6–10. 

Johnson, R.J.; Segal, M.S.; Sautin, Y.; Nakagawa, T.; Feig, D.I.; Kang, D.H.; Gersch, M.S.; 

Benner, S.; Sánchez-Lozada, L.G. (2007). Potential role of sugar (fructose) in the 

epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney 

disease, and cardiovascular disease. The American Journal of Clinical Nutrition, 86:899-

906. 

Jull, A.B.; Ni Mhurchu, C.; Bennett, D.A.; Dunshea-Mooij, C.A.; Rodgers, A. (2008). Chitosan 

for overweight or obesity. Cochrane Database System Review, 16:CD003892. 

Kaats, G.R.; Michalek, J.E.; Preuss, H.G. (2006). Evaluating eficacy of a chitosan product 

using a double-blinded, placebo-controlled protocol. Journal of the American College of 

Nutrition, 25:389-394. 

Kalyanasundaram. K.; Thomas, J.K. (1977). Environment effects on vibronic band intensities 

in pyrene monomer fluorescence and their application in studies of micellar systems. 

Journal of the American Chemical Society, 99:2039–2044. 

---